FDA Advisory Panel To Evaluate Acetaminophen Pediatric Dosing
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA expects the meeting to focus on single ingredient products, especially for children younger than 2, and to consider adding a weight-based dosing regimen to the existing age-based dosing for children 2-12.